Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Focusing on short term investment goals can yield quick financial returns. Discover the right timing for your investment strategy.
27,474 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
A new Morgan Stanley Research report argues that housing affordability unlikely return to pre-2022 levels as rates st...
Bitcoin breaks a 12-year trend against gold, signaling a shift in risk sentiment as quantum-era concerns enter mainst...
J.B. Hunt edges ahead on margin strength in a soft freight market, while ZIM faces a sharp drop in rates and merger r...
Strategy Inc. disclosed a rare bitcoin sale, sending its stock lower as investors weigh liquidity needs against the c...
Two senior DeepMind researchers left within 48 hours, jolting Alphabet's AI strategy and sending shockwaves through t...
XRP is facing renewed selling pressure across major trading pairs, with a looming test of the $1.20 support and criti...
The WNBA and the players union announced an agreement in principle on a new collective bargaining agreement, promisin...
Broadcom posted a solid quarter but guided toward softer AI chip sales, sending its stock lower and dragging peers li...
The Ethereum Foundation slashes staff by 54 and trims annual spending, triggering a leaner path for ETH. Robert Kiyos...
Finding winning stocks isn’t about chasing the hottest trend. It’s about identifying durable catalysts, solid fundame...
Geopolitical tensions and volatile oil prices have investors hunting for stock-wue winners beyond crude. Here are two...